Parkinsons Disease Therapeutics Market to 2019 : Industry Shares, Size, Trend, Analysis, and Forecasts Report Available Online by Researchmoz.us
GBI Research has released the pharma report - “Parkinson’s Disease Therapeutics Market to 2019 - Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s Disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life. There is currently there is a huge unmet need for disease-modifying treatments that slow progression or have neuroprotective properties. Over the 2012–2019 forecast...
View full press release